Article Information
PubMed
History
- Published online November 18, 2014.
Copyright & Usage
© 2014 Canadian Medical Association or its licensors
Author Information
- Tara Gomes, MHSc1,5,8,
- David Juurlink, MD, PhD1,2,4,
- Zhan Yao, MD, MS1,
- Ximena Camacho, MMath1,
- J. Michael Paterson, MSc1,5,9,
- Samantha Singh, BSc1,
- Irfan Dhalla, MD, MSc1,3,8,
- Beth Sproule, PharmD6,7,10,
- Muhammad Mamdani, PharmD, MPH3,5,6
- 1Institute for Clinical Evaluative Sciences, Toronto, Ont.
- 2Sunnybrook Research Institute, Toronto, Ont.
- 3Department of Medicine, St. Michael’s Hospital, Toronto, Ont.
- 4Department of Medicine, University of Toronto, Toronto, Ont.
- 5Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ont.
- 6Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ont.
- 7Department of Psychiatry, University of Toronto, Toronto, Ont.
- 8Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ont.
- 9Department of Family Medicine, McMaster University, Hamilton, Ont.
- 10Centre for Addiction and Mental Health, Toronto, Ont.
- Correspondence to:
Tara Gomes, GomesT{at}smh.ca
In this issue
Article tools
Respond to this article
Related Articles
Cited By...
- New opioid prescription claims and their clinical indications: results from health administrative data in Quebec, Canada, over 14 years
- Cross-sectional study of rapid tapering of opioid prescriptions following medical regulatory intervention in Alberta from 2013 to 2020
- Physician benzodiazepine self-use prior to and during the COVID-19 pandemic in Ontario, Canada: a population-level cohort study
- The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis